Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission Tomography
JUWEID, Malik E, WISEMAN, Gregory A, LINK, Brian K, RESKE, Sven N, GRAHAM, Michael M, CHESON, Bruce D, VOSE, Julie M, RITCHIE, Justine M, MENDA, Yusuf, WOOLDRIDGE, James E, MOTTAGHY, Felix M, ROHREN, Eric M, BLUMSTEIN, Norbert M, STOLPEN, Alan
Published in Journal of clinical oncology (20.07.2005)
Published in Journal of clinical oncology (20.07.2005)
Get full text
Journal Article
B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation
Jahrsdörfer, Bernd, Blackwell, Sue E., Wooldridge, James E., Huang, Jian, Andreski, Melinda W., Jacobus, Laura S., Taylor, Christiana M., Weiner, George J.
Published in Blood (15.10.2006)
Published in Blood (15.10.2006)
Get full text
Journal Article
A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma
Jourdan, Eric, Leblond, Veronique, Maisonneuve, Hervé, Benhadji, Karim A., Hossain, Anwar M., Nguyen, Tuan S., Wooldridge, James E., Moreau, Philippe
Published in Leukemia & lymphoma (01.09.2014)
Published in Leukemia & lymphoma (01.09.2014)
Get full text
Journal Article
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade–Resistant Advanced NSCLC
Negrao, Marcelo V., Papadimitrakopoulou, Vassiliki A., Price, Andrew C., Tam, Alda L., Furqan, Muhammad, Laroia, Sandeep T., Massarelli, Erminia, Pacheco, Jose, Heymach, John V., Tsao, Anne S., Walker, Gary V., Vora, Lalit, Mauro, David, Kelley, Heather, Wooldridge, James E., Krieg, Arthur M., Niu, Jiaxin
Published in JTO clinical and research reports (01.03.2023)
Published in JTO clinical and research reports (01.03.2023)
Get full text
Journal Article
Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells
Jahrsdörfer, Bernd, Wooldridge, James E., Blackwell, Sue E., Taylor, Christiana M., Griffith, Thomas S., Link, Brian K., Weiner, George J.
Published in Journal of leukocyte biology (01.03.2005)
Published in Journal of leukocyte biology (01.03.2005)
Get full text
Journal Article
Phase I study of LY2469298, an Fc‐engineered humanized anti‐CD20 antibody, in patients with relapsed or refractory follicular lymphoma
Tobinai, Kensei, Ogura, Michinori, Kobayashi, Yukio, Uchida, Toshiki, Watanabe, Takashi, Oyama, Takashi, Maruyama, Dai, Suzuki, Tatsuya, Mori, Masakazu, Kasai, Masanobu, Cronier, Damien, Wooldridge, James E., Koshiji, Minori
Published in Cancer science (01.02.2011)
Published in Cancer science (01.02.2011)
Get full text
Journal Article
Immunostimulatory Oligodeoxynucleotides Containing the CpG Motif are Effective as Immune Adjuvants in Tumor Antigen Immunization
Weiner, George J., Liu, Hsin-Ming, Wooldridge, James E., Dahle, Christopher E., Krieg, Arthur M.
Published in Proceedings of the National Academy of Sciences - PNAS (30.09.1997)
Published in Proceedings of the National Academy of Sciences - PNAS (30.09.1997)
Get full text
Journal Article
Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma
Ribas, Antoni, Medina, Theresa, Kirkwood, John M, Zakharia, Yousef, Gonzalez, Rene, Davar, Diwakar, Chmielowski, Bartosz, Campbell, Katie M, Bao, Riyue, Kelley, Heather, Morris, Aaron, Mauro, David, Wooldridge, James E, Luke, Jason J, Weiner, George J, Krieg, Arthur M, Milhem, Mohammed M
Published in Cancer discovery (01.12.2021)
Published in Cancer discovery (01.12.2021)
Get full text
Journal Article
A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer
Rosen, Lee S, Goldman, Jonathan W, Algazi, Alain P, Turner, P Kellie, Moser, Brian, Hu, Tianle, Wang, Xuejing Aimee, Tuttle, Jay, Wacheck, Volker, Wooldridge, James E, Banck, Michaela
Published in Clinical cancer research (15.04.2017)
Published in Clinical cancer research (15.04.2017)
Get full text
Journal Article
Phase 2 study of tabalumab, a human anti‐B‐cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma
Raje, Noopur S., Moreau, Philippe, Terpos, Evangelos, Benboubker, Lotfi, Grząśko, Norbert, Holstein, Sarah A., Oriol, Albert, Huang, Shang‐Yi, Beksac, Meral, Kuliczkowski, Kazimierz, Tai, Datchen F., Wooldridge, James E., Conti, Ilaria, Kaiser, Christopher J., Nguyen, Tuan S., Cronier, Damien M., Palumbo, Antonio
Published in British journal of haematology (01.03.2017)
Published in British journal of haematology (01.03.2017)
Get full text
Journal Article
Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab
Bowles, Julie A., Wang, Siao-Yi, Link, Brian K., Allan, Barrett, Beuerlein, Gregory, Campbell, Mary-Ann, Marquis, David, Ondek, Brian, Wooldridge, James E., Smith, Brian J., Breitmeyer, James B., Weiner, George J.
Published in Blood (15.10.2006)
Published in Blood (15.10.2006)
Get full text
Journal Article
Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma
Raje, Noopur S, Faber, Jr, Edward A, Richardson, Paul G, Schiller, Gary, Hohl, Raymond J, Cohen, Adam D, Forero, Andres, Carpenter, Susan, Nguyen, Tuan S, Conti, Ilaria, Kaiser, Christopher J, Cronier, Damien M, Wooldridge, James E, Anderson, Kenneth C
Published in Clinical cancer research (01.12.2016)
Published in Clinical cancer research (01.12.2016)
Get full text
Journal Article
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
Zent, Clive S., Smith, Brian J., Ballas, Zuhair K., Wooldridge, James E., Link, Brian K., Call, Timothy G., Shanafelt, Tait D., Bowen, Deborah A., Kay, Neil E., Witzig, Thomas E., Weiner, George J.
Published in Leukemia & lymphoma (01.02.2012)
Published in Leukemia & lymphoma (01.02.2012)
Get full text
Journal Article
Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma
FORERO-TORRES, Andres, DE VOS, Sven, SMITH, Mitchell R, LINK, Brian K, WOOLDRIDGE, James E, GANJOO, Kristen N, POHLMAN, Brad L, PASHKEVICH, Maksim, CRONIER, Damien M, DANG, Nam H, CARPENTER, Susan P, ALLAN, Barrett W, NELSON, James G, SLAPAK, Christopher A
Published in Clinical cancer research (01.03.2012)
Published in Clinical cancer research (01.03.2012)
Get full text
Journal Article
Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Badeaux, Mark D, Rolig, Annah S, Agnello, Giulia, Enzler, Danlee, Kasiewicz, Melissa J, Priddy, Leslie, Wiggins, Jason F, Muir, Alexander, Sullivan, Mark R, Van Cleef, Jessica, Daige, Christopher, Vander Heiden, Matthew G, Rajamanickam, Venkatesh, Wooldridge, James E, Redmond, William L, Rowlinson, Scott W
Published in Cancer immunology research (01.04.2021)
Published in Cancer immunology research (01.04.2021)
Get more information
Journal Article
Frequency of skeletal-related events and associated healthcare resource use and costs in US patients with multiple myeloma
Nash Smyth, Emily, Conti, Ilaria, Wooldridge, James E, Bowman, Lee, Li, Li, Nelson, David R, Ball, Daniel E
Published in Journal of medical economics (03.05.2016)
Published in Journal of medical economics (03.05.2016)
Get more information
Journal Article
A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenström Macroglobulinemia
GHOBRIAL, Irene M, MOREAU, Philippe, LEBLOND, Veronique, HARRIS, Brianna, POON, Tiffany, JOURDAN, Eric, MAISONNEUVE, Hervé, BENHADJI, Karim A, HOSSAIN, Anwar M, NGUYEN, Tuan S, WOOLDRIDGE, James E
Published in Clinical cancer research (15.09.2012)
Published in Clinical cancer research (15.09.2012)
Get full text
Journal Article
Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma
Link, Brian K, Ballas, Zuhair K, Weisdorf, Daniel, Wooldridge, James E, Bossler, Aaron D, Shannon, Mary, Rasmussen, Wendy L, Krieg, Arthur M, Weiner, George J
Published in Journal of immunotherapy (1997) (01.09.2006)
Published in Journal of immunotherapy (1997) (01.09.2006)
Get more information
Journal Article
Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma
Ganjoo, Kristen N., de Vos, Sven, Pohlman, Brad L., Flinn, Ian W., Forero-Torres, Andres, Enas, Nathan H., Cronier, Damien M., Dang, Nam H., Foon, Kenneth A., Carpenter, Susan P., Slapak, Christopher A., Link, Brian K., Smith, Mitchell R., Mapara, Markus Y., Wooldridge, James E.
Published in Leukemia & lymphoma (01.01.2015)
Published in Leukemia & lymphoma (01.01.2015)
Get full text
Journal Article